Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen

Decitabine has been explored as a reduced‐intensity therapy for older or unfit patients with acute myeloid leukemia (AML). To better understand the risk of infections during decitabine treatment, we retrospectively examined the culture results from each infection‐related serious adverse event that o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Ali, Alaa M., Weisel, Daniel, Gao, Feng, Uy, Geoffrey L., Cashen, Amanda F., Jacoby, Meagan A., Wartman, Lukas D., Ghobadi, Armin, Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A., Stockerl‐Goldstein, Keith E., Vij, Ravi, Oh, Stephen T., Abboud, Camille N., Schroeder, Mark A., Westervelt, Peter, DiPersio, John F., Welch, John S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727246/
https://ncbi.nlm.nih.gov/pubmed/29058375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1231
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia